VEGF Blockade May Slow, but Not Halt, Progression in DME

High VEGF, as well as glucotoxicity or other causes, may hasten progression of retinal nonperfusion in diabetic macular edema, suggesting ranibizumab may not prevent retinal capillary closure.
Medscape Medical News